Search
for
Sort by
Research 61–90 of 337
- Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors
- Dermatologic Adverse Events from Cancer Treatments
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- Diagnosis and Management of Melanoma of the Scalp: A Review of the Literature
- Resolution of paraneoplastic alopecia areata following nivolumab in a patient with metastatic melanoma
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Research Progress on the Application of Stem Cells in Hair Regeneration
- 612 Wnt signaling induces fibrotic fat loss via DPP4 in skin fibrosis
- Poster Presentations
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- The Aldo-Keto Reductase AKR1B10 Is Up-Regulated in Keloid Epidermis, Implicating Retinoic Acid Pathway Dysregulation in the Pathogenesis of Keloid Disease
- Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case
- Exploiting the origins of Ras mediated squamous cell carcinoma to develop novel therapeutic interventions
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Oncogenic senescence: a multi-functional perspective
- Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein Model
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Drug Repurposing against KRAS Mutant G12C: A Machine Learning, Molecular Docking, and Molecular Dynamics Study
- Malignant epithelial tumors: Part II. Therapy and prevention
- Treatment of Hair Loss
- PAK4 signaling in health and disease: defining the PAK4–CREB axis
- Targeting the Warburg Effect in Anaplastic Thyroid Carcinoma: Metabolic Vulnerabilities and Therapeutic Opportunities
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment